NASDAQ:AQB - Nasdaq - US03842K3095 - Common Stock - Currency: USD
0.6778
+0.02 (+2.7%)
The current stock price of AQB is 0.6778 USD. In the past month the price decreased by -9.63%. In the past year, price decreased by -69.05%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 21.17 | 378.30B | ||
AMGN | AMGEN INC | 16.39 | 174.51B | ||
GILD | GILEAD SCIENCES INC | 25.47 | 146.22B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 1683.76 | 125.39B | ||
REGN | REGENERON PHARMACEUTICALS | 15.5 | 77.34B | ||
ARGX | ARGENX SE - ADR | 231.21 | 36.10B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 31.66B | ||
ONC | BEIGENE LTD-ADR | N/A | 26.47B | ||
BNTX | BIONTECH SE-ADR | N/A | 26.08B | ||
BIIB | BIOGEN INC | 9.13 | 22.01B | ||
NTRA | NATERA INC | N/A | 19.02B | ||
GMAB | GENMAB A/S -SP ADR | 24.89 | 15.34B |
AquaBounty Technologies, Inc. engages in the provision of land-based aquaculture services. The company is headquartered in Harvard, Massachusetts and currently employs 104 full-time employees. The company went IPO on 2017-01-09. The firm provides fresh Atlantic salmon to nearby markets by raising its fish in monitored land-based fish farms. Its land-based Recirculating Aquaculture System (RAS) farms, including a grow-out farm located in Indiana, United States and a broodstock and egg production farm located on Prince Edward Island, Canada, are designed to prevent disease and to include multiple levels of fish containment to protect wild fish populations. RAS facilities provide water treatment technology, including the use of ozone, salt treatment and ultraviolet radiation to kill potential bacterial, fungal, or viral pathogens which might enter the system. The firm is vertically integrated and maintains its own broodstock hatchery, which produces the eggs that it grow-out to harvest size in its production farms. The firm has expertise in fish breeding, genetics, and health and nutrition to deliver disruptive solutions.
AQUABOUNTY TECHNOLOGIES
233 Ayer Road Suite 4, Suite 4
Harvard MASSACHUSETTS 01754 US
CEO: Sylvia A. Wulf
Employees: 104
Company Website: https://aquabounty.com/
Investor Relations: https://investors.aquabounty.com/
Phone: 19786486000
The current stock price of AQB is 0.6778 USD. The price increased by 2.7% in the last trading session.
The exchange symbol of AQUABOUNTY TECHNOLOGIES is AQB and it is listed on the Nasdaq exchange.
AQB stock is listed on the Nasdaq exchange.
8 analysts have analysed AQB and the average price target is 1.02 USD. This implies a price increase of 50.49% is expected in the next year compared to the current price of 0.6778. Check the AQUABOUNTY TECHNOLOGIES stock analysts ratings, price target forecast and up-and down grades for more detailed information.
AQUABOUNTY TECHNOLOGIES (AQB) has a market capitalization of 2.62M USD. This makes AQB a Nano Cap stock.
AQUABOUNTY TECHNOLOGIES (AQB) currently has 104 employees.
AQUABOUNTY TECHNOLOGIES (AQB) has a support level at 0.67 and a resistance level at 0.68. Check the full technical report for a detailed analysis of AQB support and resistance levels.
The Revenue of AQUABOUNTY TECHNOLOGIES (AQB) is expected to decline by -65.64% in the next year. Check the estimates tab for more information on the AQB EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AQB does not pay a dividend.
AQUABOUNTY TECHNOLOGIES (AQB) will report earnings on 2025-03-31, after the market close.
AQUABOUNTY TECHNOLOGIES (AQB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-7.54).
The outstanding short interest for AQUABOUNTY TECHNOLOGIES (AQB) is 3.98% of its float. Check the ownership tab for more information on the AQB short interest.
ChartMill assigns a technical rating of 1 / 10 to AQB. When comparing the yearly performance of all stocks, AQB is a bad performer in the overall market: 93.54% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to AQB. AQB may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months AQB reported a non-GAAP Earnings per Share(EPS) of -7.54. The EPS decreased by -10.88% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -62.4% | ||
ROE | -73.45% | ||
Debt/Equity | 0.05 |
ChartMill assigns a Buy % Consensus number of 45% to AQB. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -136.44% and a revenue growth -65.64% for AQB